Compile Data Set for Download or QSAR

Found 3 hits of ic50 for UniProtKB: P08648   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-5/beta-8 (Homo sapiens (Human))	BDBM297773 (US10118929, Compound A1) Show SMILES OC(=O)CC(N1CCN(CCCCNc2nc3ccccc3[nH]2)C1=O)c1cccc(c1)C(F)(F)F Show InChI	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	50.4	n/a	n/a	n/a	n/a	n/a	n/a
SciFluor Life Sciences, Inc. US Patent					Assay Description The optimized protocol was validated by employing reference compounds such as Cilengitide (+Vβ3/αVβ5−VN interaction) and CWHM12 ...				US Patent US10118929 (2018) BindingDB Entry DOI: 10.7270/Q2V126WM
					More data for this Ligand-Target Pair
Integrin alpha-5/beta-8 (Homo sapiens (Human))	BDBM297775 (US10118929, Compound A10) Show SMILES OC(=O)CC(N1CCN(CCCCNc2ccccn2)C1=O)c1cccc(c1)C(F)(F)F Show InChI InChI=1S/C22H25F3N4O3/c23-22(24,25)17-7-5-6-16(14-17)18(15-20(30)31)29-13-12-28(21(29)32)11-4-3-10-27-19-8-1-2-9-26-19/h1-2,5-9,14,18H,3-4,10-13,15H2,(H,26,27)(H,30,31)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	232	n/a	n/a	n/a	n/a	n/a	n/a
SciFluor Life Sciences, Inc. US Patent					Assay Description The optimized protocol was validated by employing reference compounds such as Cilengitide (+Vβ3/αVβ5−VN interaction) and CWHM12 ...				US Patent US10118929 (2018) BindingDB Entry DOI: 10.7270/Q2V126WM
					More data for this Ligand-Target Pair
Integrin alpha-5/beta-8 (Homo sapiens (Human))	BDBM297774 (US10118929, Compound A8) Show SMILES OC(=O)CC(N1CCN(CCCCNC2=NCc3ccccc3C2)C1=O)c1cccc(c1)C(F)(F)F |t:14| Show InChI InChI=1S/C26H29F3N4O3/c27-26(28,29)21-9-5-8-19(14-21)22(16-24(34)35)33-13-12-32(25(33)36)11-4-3-10-30-23-15-18-6-1-2-7-20(18)17-31-23/h1-2,5-9,14,22H,3-4,10-13,15-17H2,(H,30,31)(H,34,35)	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	622	n/a	n/a	n/a	n/a	n/a	n/a
SciFluor Life Sciences, Inc. US Patent					Assay Description The optimized protocol was validated by employing reference compounds such as Cilengitide (+Vβ3/αVβ5−VN interaction) and CWHM12 ...				US Patent US10118929 (2018) BindingDB Entry DOI: 10.7270/Q2V126WM
					More data for this Ligand-Target Pair